3/16
11:05 pm
asrt
Assertio Holdings Inc (ASRT) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
Low
Report
Assertio Holdings Inc (ASRT) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
3/16
06:15 pm
asrt
Assertio Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Assertio Q4 Earnings Call Highlights [Yahoo! Finance]
3/16
06:07 pm
asrt
Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/16
06:04 pm
asrt
Assertio outlines $110M–$125M 2026 revenue target with Rolvedon at the core while shifting business development approach [Seeking Alpha]
Low
Report
Assertio outlines $110M–$125M 2026 revenue target with Rolvedon at the core while shifting business development approach [Seeking Alpha]
3/16
05:57 pm
asrt
Assertio (ASRT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Assertio (ASRT) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/16
05:32 pm
asrt
Assertio Holdings Non-GAAP EPS of -$1.06 beats by $0.74, revenue of $13.52M beats by $7.32M [Seeking Alpha]
Low
Report
Assertio Holdings Non-GAAP EPS of -$1.06 beats by $0.74, revenue of $13.52M beats by $7.32M [Seeking Alpha]
3/16
04:37 pm
asrt
Assertio: Q4 Earnings Snapshot [Yahoo! Finance]
Medium
Report
Assertio: Q4 Earnings Snapshot [Yahoo! Finance]
3/16
04:33 pm
asrt
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/16
04:05 pm
asrt
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results
3/14
02:11 pm
asrt
Assertio Holdings Q4 2025 Earnings Preview [Seeking Alpha]
Low
Report
Assertio Holdings Q4 2025 Earnings Preview [Seeking Alpha]
3/13
07:42 am
asrt
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/10
06:21 am
asrt
Assertio (ASRT) was downgraded by Zacks Research from "strong-buy" to "hold".
Low
Report
Assertio (ASRT) was downgraded by Zacks Research from "strong-buy" to "hold".
3/8
08:44 pm
asrt
How Assertio Holdings (ASRT) Narrative Is Shifting Around A Steady 37.44 Fair Value Target [Yahoo! Finance]
Low
Report
How Assertio Holdings (ASRT) Narrative Is Shifting Around A Steady 37.44 Fair Value Target [Yahoo! Finance]
3/3
04:30 pm
asrt
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Medium
Report
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
1/23
05:06 am
asrt
Assertio (NASDAQ:ASRT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Assertio (NASDAQ:ASRT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/12
04:39 pm
asrt
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements [Yahoo! Finance]
High
Report
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements [Yahoo! Finance]
1/12
04:24 pm
asrt
Assertio regains Nasdaq compliance after bid price recovery [Seeking Alpha]
High
Report
Assertio regains Nasdaq compliance after bid price recovery [Seeking Alpha]
1/12
04:15 pm
asrt
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
High
Report
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements
1/11
09:26 pm
asrt
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story [Yahoo! Finance]
Low
Report
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story [Yahoo! Finance]
1/9
01:45 pm
asrt
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
Low
Report
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial
1/5
07:17 am
asrt
Assertio (NASDAQ:ASRT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Assertio (NASDAQ:ASRT) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/1
05:45 am
asrt
Assertio (NASDAQ:ASRT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Assertio (NASDAQ:ASRT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.